Samantha Semenkow

Stock Analyst at Citigroup

(0)
# 4870
Out of 5,327 analysts
47
Total ratings
20.00%
Success rate
-27.30%
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
ARGX argenx
Maintains: Strong Buy
681 796
613.59 29.73% 5 Apr 17, 2025
BIOA Bioage Labs
Maintains: Neutral
7 5
4.46 12.11% 3 Mar 24, 2025
SLRN Acelyrin
Maintains: Neutral
6 3
n/a n/a 2 Jan 7, 2025
VYGR Voyager Therapeutics
Initiates Coverage On: Buy
12
3.46 246.82% 1 Dec 2, 2024
ALLO Allogene Therapeutic...
Maintains: Strong Buy
7 8
1.6 400% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
27 31
23.56 31.58% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 15
1.71 777.19% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
4
0.38 952.63% 2 Jun 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
10 14
2.25 522.22% 6 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
10
1.67 498.8% 2 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 15
1.58 849.37% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
9 12
4.99 140.48% 2 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
26 30
1.27 2262.2% 2 Apr 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
72
39.05 84.38% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
n/a n/a 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
33 50
15.21 228.73% 3 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 56
19.45 187.92% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 1
n/a n/a 3 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
n/a n/a 1 May 3, 2023